BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 132382)

  • 1. Studies on streptozotocin diabetes.
    Ganda OP; Rossini AA; Like AA
    Diabetes; 1976 Jul; 25(7):595-603. PubMed ID: 132382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of alloxan toxicity on the beta cell.
    Rossini AA; Arcangeli MA; Cahill GF
    Diabetes; 1975 May; 24(5):516-22. PubMed ID: 1092583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrasting modes of action of D-glucose and 3-O-methyl-D-glucose as protectors of the rat pancreatic B-cell against alloxan.
    Malaisse-Lagae F; Sener A; Malaisse WJ
    Biochim Biophys Acta; 1983 Feb; 762(1):36-43. PubMed ID: 6338936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose and 3-O-methylglucose protection against alloxan poisoning of pancreatic alpha and beta cells.
    Pagliara AS; Stillings SN; Zawalich WS; Williams AD; Matchinsky FM
    Diabetes; 1977 Oct; 26(10):973-9. PubMed ID: 332568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proinsulin biosynthesis by pancreatic islets of the rat and the study of alloxan cytotoxicity in vitro.
    Jain K; Logothetopoulos J
    Biochim Biophys Acta; 1976 Jun; 435(2):145-51. PubMed ID: 779842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of hexoses and mannoheptulose on cyclic AMP accumulation and insulin secretion in rat pancreatic islets.
    Grill V; Cerasi E
    Biochim Biophys Acta; 1976 Jun; 437(1):36-50. PubMed ID: 181079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the effects of streptozotocin, N-methylnitrosourea and alloxan on isolated islets of Langerhans.
    Akpan JO; Wright PH; Dulin WE
    Diabete Metab; 1987 Apr; 13(2):122-8. PubMed ID: 2954869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies on the mechanism of the diabetogenic activity of streptozotocin and on the ability of compounds to block the diabetogenic activity of streptozotocin (author's transl)].
    Doi K
    Nihon Naibunpi Gakkai Zasshi; 1975 Mar; 51(3):129-47. PubMed ID: 169168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta cell protection to alloxan necrosis by anomers of D-glucose.
    Rossini AA; Berger M; Shadden J; Cahill GF
    Science; 1974 Feb; 183(4123):424. PubMed ID: 4587675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting the beta-cell sensitivity to alloxan in vivo. Influence of pre- and post-treatment with protective substances.
    Boquist L
    Acta Endocrinol (Copenh); 1978 Jul; 88(3):556-61. PubMed ID: 354301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic beta cell toxicity by streptozotocin anomers.
    Rossini AA; Like AA; Dulin WE; Cahill GF
    Diabetes; 1977 Dec; 26(12):1120-4. PubMed ID: 145386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of 2-deoxy-d-glucose and 3-O-methyl-d-glucose on mucosubstance secretion in cell culture.
    Duguid R; Marsden JC
    Biochem Soc Trans; 1975; 3(4):498-9. PubMed ID: 171181
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of streptozotocin-induced alterations in the rat heart by 3-O-methyl glucose and insulin treatments.
    Ramanadham S; Young J; Tenner TE
    J Cardiovasc Pharmacol; 1987 Mar; 9(3):291-7. PubMed ID: 2437395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of retinyl palmitate on streptozotocin- and alloxan-induced beta cell toxicity and diabetes in the rat.
    Chertow BS; Webb MD; Leidy JW; Cordle MB
    Res Commun Chem Pathol Pharmacol; 1989 Jan; 63(1):27-44. PubMed ID: 2521747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The protective effect of glucose, but not 3-O-methyl glucose, against alloxan-induced diabetes depends upon the route of hexose administration.
    Jansson L; Sandler S
    Arch Int Pharmacodyn Ther; 1988; 293():257-64. PubMed ID: 3048222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the blood glucose response of mice to alloxan and alloxan-inhibiting compounds.
    Boquist L
    Acta Endocrinol (Copenh); 1979 Dec; 92(4):687-93. PubMed ID: 532524
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro.
    Gai W; Schott-Ohly P; Schulte im Walde S; Gleichmann H
    Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):29-37. PubMed ID: 14758569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective role of superoxide dismutase against diabetogenic drugs.
    Gandy SE; Buse MG; Crouch RK
    J Clin Invest; 1982 Sep; 70(3):650-8. PubMed ID: 6213639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alloxan-induced glucoprivic feeding deficits are blocked by D-glucose and amygdalin.
    Murnane JM; Ritter S
    Pharmacol Biochem Behav; 1985 Mar; 22(3):407-13. PubMed ID: 3991757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of iodoacetate, mannoheptulose and 3-O-methyl glucose on the secretory function and metabolism of isolated pancreatic islets.
    Zawalich WS; Pagliara AS; Matschinsky FM
    Endocrinology; 1977 May; 100(5):1276-83. PubMed ID: 321218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.